Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT04851860
Eligibility Criteria:
Inclusion Criteria:
* 1\. Children with moderate to severe allergic rhinitis according to Allergic Rhinitis And Its Impact On Asthma (ARIA) guidelines\[9\], which interfere with daily activity or sleep.
2\. Children aged (6-12) years with clinical history of allergic rhinitis for at least one year.
3\. Children with allergic rhinitis who failed medical treatment, desire an alternative to pharmacotherapy.
4\. Sex : male and female.
Exclusion Criteria:
\- 1. Children with chronic lung \& heart diseases as: asthma and anatomical malformation for respiratory system.
2\. disorders: Gastro Esophageal Reflux Disease, cystic fibrosis and epilepsy. 3.Children with chronic drug use: oral or nasal corticosteroids, antiepileptic and immunosuppressive.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
12 Years
Study:
NCT04851860
Study Brief:
Protocol Section:
NCT04851860